Wednesday, August 10, 2016

Injectable Tamoxifen Citrate Nolvadex Anti Estrogen Steroids No Side Effects

Injectable Tamoxifen Citrate Nolvadex Anti Estrogen Steroids No Side Effects

email: smile@ok-biotech.com
skype: onsellsteroids
whatsapp: +8618924660950
www.ok-biotech.com

Nolvadex (tamoxifen citrate) is very comparable to Clomid, behaves in the same manner in all tissues, and is a mixed estrogen agonist/antagonist of the same type as Clomid. The two molecules are also very similar in structure.

Alias: Nolvadex;TAM
CAS No: 10540-29-1
Einecs No: 234-118-0
MF: C26H29NO
MW: 371.51 
Purity: 99%
Apperance: white to off-white powder
Usage: estrogen antagonist,antineoplastic


IMG_2218

Description:

Nolvadex (tamoxifen citrate) is very comparable to Clomid, behaves in the same manner in all tissues, and is a mixed estrogen agonist/antagonist of the same type as Clomid. The two molecules are also very similar in structure.

Applications:

Antitumor drugs raw material, suitable for breast cancer.It is not correct that Nolvadex reduces levels of estrogen: rather, it blocks estrogen from estrogen receptors and, in those tissues where it is an antagonist, causes the receptor to do nothing. Nolvadex isnotan anabolic steroid but is used to manage side effects from steroids.
Biological Activity: Estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo . Also high affinity agonist at the membrane estrogen receptor GPR30.


Specifications:

Test ItemsSpecificationTest Results
DescriptionWhite crystalline powderWhite crystalline powder
IdentificationIR , UV conformConform
Loss on drying≤0.5ml0.21ml
Residue on ignitionNot more than 0.2%0.06ml
IronNot more than 0.005%0.0018%
Heavy metalsNot more than 0.001%0.0006%
Related substances
Total: Not more than 1.0%
Individual: Not more than 0.5%
0.32%
0.14%
E-isomerNot more than 0.3%0.19%
Organic volatile impuritiesConformsConforms
Assay99.0~101.0%99.51%
ConclusionConform with USP30

No comments:

Post a Comment